Pamela Stephenson, Director at Zynerba Pharmaceuticals, Inc. (ZYNE), sold 40 shares at $1.01 ($40) on 2022-06-14, disclosed to the SEC on 2022-06-16.
Open-market sale of $40 ZYNE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ZYNE | SELL | 2023-06-15 | $40 | — | Filing → |
| ALBO | SELL | 2023-01-23 | $4K | — | Filing → |
| ALBO | SELL | 2023-01-20 | $156K | — | Filing → |